New imaging injection for suspected prostate cancer recurrence
Part of Cancer, Kidney & urinary clinical trials.
This trial tests a new imaging injection (INR101) to help find where prostate cancer may have returned after your first treatment. It uses PET/CT scans to spot cancer cells more clearly.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man aged 18 years or older
- You are physically able to carry out daily tasks (ECOG score 0 or 1)
- You have been diagnosed with prostate cancer that came back after your first treatment (seen as a rise in PSA)
- Your blood counts and liver/kidney function meet basic safety levels
- You have no other recent cancers (except some easily treated skin or bladder cancers)
- You have not had a hip replacement or broken bones in the past year
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new imaging agent (INR101) used with a PET/CT scan to help see prostate cancer before surgery. The scan may help doctors plan your prostate removal surgery more accurately.
This study tests a new imaging drug called Flotufolastat F-18 to find prostate cancer that has returned after treatment. The goal is to see how well and safely it finds the cancer spots, which could help guide next steps.
This study tests a new experimental treatment for advanced prostate cancer that has spread and no longer responds to standard hormone therapy. The treatment is a radioactive drug that targets a protein called PSMA on cancer cells, aiming to deliver radiation directly to the tumor.
This study tests an investigational imaging agent, HRS-1738, to see if it can help detect prostate cancer during a PET/CT scan. It may help doctors better see and diagnose prostate cancer.
This trial tests a new investigational drug called INR102 for prostate cancer that has spread and stopped responding to standard treatments. It's given by injection, and the study will check if it's safe and if it can shrink or slow the cancer.
This study tests a new type of PET scan (a detailed imaging test) to find out if prostate cancer has come back after treatment. You'll receive an injection of a special tracer and then have a scan that takes pictures to help doctors locate any cancer.
Hear when a new Prostate Cancer Recurrent trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.